Search Results

There are 24111 results for: content related to: Clinical pattern and associations of oxaliplatin acute neurotoxicity

  1. Integrin beta-3 L33P: a new insight into the pathogenesis of chronic oxaliplatin-induced peripheral neuropathy?

    European Journal of Neurology

    Volume 17, Issue 7, July 2010, Pages: 963–968, A. G. Antonacopoulou, A. A. Argyriou, C. D. Scopa, A. Kottorou, A. Kominea, S. Peroukides and H. P. Kalofonos

    Version of Record online : 23 FEB 2010, DOI: 10.1111/j.1468-1331.2010.02966.x

  2. Ultrasound assessment of oxaliplatin-induced neuropathy and correlations with neurophysiologic findings

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 188–192, C. Briani, M. Campagnolo, M. Lucchetta, M. Cacciavillani, C. Dalla Torre, G. Granata, F. Bergamo, S. Lonardi, V. Zagonel, G. Cavaletti, M. Ermani and L. Padua

    Version of Record online : 4 SEP 2012, DOI: 10.1111/j.1468-1331.2012.03852.x

  3. Clinical application of oxaliplatin in epithelial ovarian cancer

    International Journal of Gynecological Cancer

    Volume 16, Issue 5, September/October 2006, Pages: 1717–1732, S. FU, J.J. KAVANAGH, W. HU and R.C. BAST Jr

    Version of Record online : 17 JUL 2006, DOI: 10.1111/j.1525-1438.2006.00654.x

  4. Effects of oxaliplatin and oleic acid Gc-protein-derived macrophage-activating factor on murine and human microglia

    Journal of Neuroscience Research

    Volume 93, Issue 9, September 2015, Pages: 1364–1377, Jacopo J.V. Branca, Gabriele Morucci, Francesca Malentacchi, Stefania Gelmini, Marco Ruggiero and Stefania Pacini

    Version of Record online : 18 MAR 2015, DOI: 10.1002/jnr.23588

  5. You have full text access to this OnlineOpen article
    Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors

    EMBO Molecular Medicine

    Volume 3, Issue 5, May 2011, Pages: 266–278, Juliette Descoeur, Vanessa Pereira, Anne Pizzoccaro, Amaury Francois, Bing Ling, Violette Maffre, Brigitte Couette, Jérôme Busserolles, Christine Courteix, Jacques Noel, Michel Lazdunski, Alain Eschalier, Nicolas Authier and Emmanuel Bourinet

    Version of Record online : 24 MAR 2011, DOI: 10.1002/emmm.201100134

  6. You have free access to this content
    PKC/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects

    International Journal of Cancer

    Volume 137, Issue 1, 1 July 2015, Pages: 243–250, Masanobu Tsubaki, Tomoya Takeda, Tadahumi Tani, Hirotaka Shimaoka, Naohiro Suzuyama, Kotaro Sakamoto, Arisa Fujita, Naoki Ogawa, Tatsuki Itoh, Motohiro Imano, Yoshinori Funakami, Seiji Ichida, Takao Satou and Shozo Nishida

    Version of Record online : 8 DEC 2014, DOI: 10.1002/ijc.29367

  7. You have free access to this content
    Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma

    FEBS Letters

    Volume 529, Issue 2-3, October 09, 2002, Pages: 232–236, Isabelle Gourdier, Maguy Del Rio, Laure Crabbé, Laurent Candeil, Virginie Copois, Marc Ychou, Charles Auffray, Pierre Martineau, Nadir Mechti, Yves Pommier and Bernard Pau

    Version of Record online : 11 SEP 2002, DOI: 10.1016/S0014-5793(02)03347-1

  8. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo

    Clinical and Experimental Pharmacology and Physiology

    Volume 40, Issue 6, June 2013, Pages: 371–378, Virginia Ip, Johnson J Liu and Mark J McKeage

    Version of Record online : 28 MAY 2013, DOI: 10.1111/1440-1681.12088

  9. You have full text access to this OnlineOpen article
    Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin-induced neuropathic cold hypersensitivity

    Pharmacology Research & Perspectives

    Volume 4, Issue 1, February 2016, Yuka Shidahara, Shinya Ogawa, Mari Nakamura, Shingo Nemoto, Yuji Awaga, Miyuki Takashima, Aldric Hama, Akihisa Matsuda and Hiroyuki Takamatsu

    Version of Record online : 8 FEB 2016, DOI: 10.1002/prp2.216

  10. Comparative analysis of the mutagenic activity of oxaliplatin and cisplatin in the Hprt gene of CHO cells

    Environmental and Molecular Mutagenesis

    Volume 46, Issue 2, 2005, Pages: 104–115, Maria J. Silva, Paula Costa, Anabela Dias, Marco Valente, Henriqueta Louro and Maria G. Boavida

    Version of Record online : 10 MAY 2005, DOI: 10.1002/em.20138

  11. Efficacy of the GemOx-R regimen leads to the identification of Oxaliplatin as a highly effective drug against Mantle Cell Lymphoma

    British Journal of Haematology

    Antònia Obrador-Hevia, Margalida Serra-Sitjar, José Rodríguez, Lamiae Belayachi, Leyre Bento, Marta García-Recio, Jose María Sánchez, Priam Villalonga, Antonio Gutiérrez and Silvia Fernández de Mattos

    Version of Record online : 25 MAY 2016, DOI: 10.1111/bjh.14141

  12. You have free access to this content
    Ursodeoxycholic acid switches oxaliplatin-induced necrosis to apoptosis by inhibiting reactive oxygen species production and activating p53-caspase 8 pathway in HepG2 hepatocellular carcinoma

    International Journal of Cancer

    Volume 126, Issue 7, 1 April 2010, Pages: 1582–1595, Sung-Chul Lim, Jeong Eun Choi, Ho Sung Kang and Han SI

    Version of Record online : 2 SEP 2009, DOI: 10.1002/ijc.24853

  13. You have free access to this content
    Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer


    Volume 118, Issue 17, 1 September 2012, Pages: 4309–4320, Hanna K. Sanoff, William R. Carpenter, Janet Freburger, Ling Li, Kun Chen, Leah L. Zullig, Richard M. Goldberg, Maria J. Schymura and Deborah Schrag

    Version of Record online : 31 JAN 2012, DOI: 10.1002/cncr.27422

  14. Capecitabine plus oxaliplatin vs fluorouracil plus oxaliplatin as first line treatment for metastatic colorectal caner – meta-analysis of six randomized trials

    Colorectal Disease

    Volume 12, Issue 1, January 2010, Pages: 16–23, Y. Cao, C. Liao, A. Tan, L. Liu, Z. Mo and F. Gao

    Version of Record online : 7 FEB 2009, DOI: 10.1111/j.1463-1318.2009.01803.x

  15. Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model

    European Journal of Pain

    Volume 15, Issue 4, April 2011, Pages: 344–350, Takehiro Kawashiri, Nobuaki Egashiral, Hitomi Watanabe, Yoko Ikegami, Shingo Hirakawa, Yuki Mihara, Takahisa Yano, Hiroaki Ikesue and Ryozo Oishi

    Version of Record online : 13 JAN 2012, DOI: 10.1016/j.ejpain.2010.08.006

  16. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: A matched-pair analysis

    Journal of Surgical Oncology

    Volume 107, Issue 6, 1 May 2013, Pages: 574–578, Gabriel Glockzin, Philipp von Breitenbuch, Hans J. Schlitt and Pompiliu Piso

    Version of Record online : 25 JUL 2012, DOI: 10.1002/jso.23228

  17. A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors

    Pediatric Blood & Cancer

    Volume 60, Issue 2, February 2013, Pages: 230–236, Margaret E. Macy, Tracey Duncan, James Whitlock, Stephen P. Hunger, Jessica Boklan, Aru Narendran, Cynthia Herzog, Robert J. Arceci, Rochelle Bagatell, Tanya Trippett, Uwe Christians, Katherine Rolla, S. Percy Ivy, Lia Gore and on behalf of the Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC)

    Version of Record online : 28 SEP 2012, DOI: 10.1002/pbc.24278

  18. Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer

    Journal of Gastroenterology and Hepatology


    Version of Record online : 8 SEP 2005, DOI: 10.1111/j.1440-1746.2005.04022.x

  19. You have free access to this content
    Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients


    Volume 118, Issue 12, 15 June 2012, Pages: 3173–3181, C. Daniel Mullins, Fei-Yuan Hsiao, Eberechukwu Onukwugha, Naimish B. Pandya and Nader Hanna

    Version of Record online : 21 OCT 2011, DOI: 10.1002/cncr.26613

  20. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody and/or drug-induced nonimmunologic protein adsorption


    Volume 49, Issue 4, April 2009, Pages: 711–718, Patricia Arndt, George Garratty, Edahn Isaak, Michael Bolger and Qun Lu

    Version of Record online : 15 DEC 2008, DOI: 10.1111/j.1537-2995.2008.02028.x